At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
VABIP Study (Vaginal Biorevitalization With Polydeoxyribonucleotides) for the Improvement of the Genitourinary Syndrome of Menopause
In Brief
A clinical study evaluating 3 g Polynucleotide vaginal suppositories and Conjugated estrogens cream 1g Tube for Genitourinary Syndrome of Menopause and 3 related conditions. Completed, enrolled 136 participants across 1 site.
Detailed Summary
The aim of the study was to compare the efficacy of vaginal biorevitalization to improve the genitourinary syndrome of menopause (GSM) between the gold-standard treatment with local estrogen-based hormone therapy versus local salmon polydeoxyribonucleotide (PDRN) therapy.
Study Details
Timeline
Interventions
3 g polynucleotide vaginal suppositories were administered nightly for 6 days.
Conjugated estrogen cream 1g was applied intravaginally on Monday, Wednesday and Friday for three months.